{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:25:11Z","timestamp":1781065511892,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970448"],"award-info":[{"award-number":["81970448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1106504"],"award-info":[{"award-number":["2018YFC1106504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.clbc.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:03:35Z","timestamp":1684465415000},"page":"628-639.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Conditional Cancer-Specific Survival for Inflammatory Breast Cancer: Analysis of SEER, 2010 to 2016"],"prefix":"10.1016","volume":"23","author":[{"given":"Shouqiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4259-4479","authenticated-orcid":false,"given":"Chong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2023.05.005_bib0001","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.7150\/jca.31176","article-title":"Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium","volume":"10","author":"Devi","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0002","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2023.05.005_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/era.09.90","article-title":"Biology and management of inflammatory breast cancer","volume":"10","author":"Dawood","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.clbc.2023.05.005_bib0004","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/cncr.25178","article-title":"Inflammatory breast cancer: The Royal Marsden Hospital experience: a review of 155 patients treated from 1990 to 2007","volume":"116","author":"Sutherland","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdm480","article-title":"Inflammatory breast cancer in Tunisia in the era of multimodality therapy","volume":"19","author":"Labidi","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0006","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1634\/theoncologist.2012-0039","article-title":"Inflammatory breast cancer: what we know and what we need to learn","volume":"17","author":"Yamauchi","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2023.05.005_bib0007","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/JTO.0000000000000649","article-title":"Conditional survival of esophageal cancer: an analysis from the SEER registry (1988-2011)","volume":"10","author":"Kim","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ssu.2980100103","article-title":"On the estimation of survival","volume":"10","author":"Henson","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0009","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/BRS.0000000000003494","article-title":"Conditional survival analysis for spinal chondrosarcoma patients after surgical resection","volume":"45","author":"Song","year":"2020","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.clbc.2023.05.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100756","article-title":"Conditional survival for high-risk early-stage cervical cancer patients with lymph node metastasis after hysterectomy","volume":"45","author":"Yang","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0011","article-title":"Conditional survival of advanced epithelial ovarian cancer: a real-world data retrospective cohort study from the SEER Database","volume":"8","author":"Zheng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clbc.2023.05.005_bib0012","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2014.11.025","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"67","author":"Collins","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1634\/theoncologist.2011-0196","article-title":"Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer","volume":"16","author":"Li","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2023.05.005_bib0014","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1704458","article-title":"Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment","volume":"33","author":"Bertucci","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clbc.2023.05.005_bib0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10549-019-05385-8","article-title":"Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database","volume":"178","author":"Liu","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.05.005_bib0016","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1200\/JCO.2003.04.521","article-title":"Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark","volume":"21","author":"Skuladottir","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0017","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1634\/theoncologist.8-2-141","article-title":"Update on the management of inflammatory breast cancer","volume":"8","author":"Cristofanilli","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2023.05.005_bib0018","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/bcr89","article-title":"Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants","volume":"2","author":"Kleer","year":"2000","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2023.05.005_bib0019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-018-0010-y","article-title":"Inflammatory breast cancer biology: the tumour microenvironment is key","volume":"18","author":"Lim","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0020","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2004.04.068","article-title":"Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy","volume":"22","author":"Low","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.05.005_bib0021","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1002\/cam4.2470","article-title":"Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer","volume":"8","author":"Diao","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2023.05.005_bib0022","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.12659\/MSM.919458","article-title":"Construction and validation of nomograms for predicting overall survival and cancer-specific survival in nonmetastatic inflammatory breast cancer patients receiving tri-modality therapy: a population-based study","volume":"25","author":"Huang","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clbc.2023.05.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211016371","article-title":"Nomograms for estimating cause-specific death rates of patients with inflammatory breast cancer: a competing-risks analysis","volume":"20","author":"Xu","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.05.005_bib0024","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/1097-0142(19950715)76:2<237::AID-CNCR2820760213>3.0.CO;2-J","article-title":"Conditional survival of 56,268 patients with breast cancer","volume":"76","author":"Henson","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0025","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.7150\/jca.46183","article-title":"Conditional survival of female patients with operable invasive breast cancer in US: a population-based study","volume":"11","author":"Ai","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.clbc.2023.05.005_bib0026","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/10543406.2017.1405012","article-title":"Statistical methods for conditional survival analysis","volume":"28","author":"Jung","year":"2018","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.clbc.2023.05.005_bib0027","doi-asserted-by":"crossref","first-page":"44","DOI":"10.6004\/jnccn.2019.7350","article-title":"Conditional survival of patients with nonmetastatic renal cell carcinoma: how cancer-specific mortality changes after nephrectomy","volume":"18","author":"Palumbo","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2023.05.005_bib0028","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cas.14231","article-title":"Conditional survival and recurrence of remnant gastric cancer after surgical resection: a multi-institutional study","volume":"111","author":"Chen","year":"2020","journal-title":"Cancer Sci"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:57Z","timestamp":1761513957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1526820923001106"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conditional Cancer-Specific Survival for Inflammatory Breast Cancer: Analysis of SEER, 2010 to 2016","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}